IP Library Granted Patent US 11,219,586
Granted Patent B2
US 11,219,586 · App. 17/375,512 · Granted Jan 11, 2022

Compositions and methods for delivering cannabinoids to skin

Inventors: Diva Chan (Emeryville, CA); Ro Oteri (Emeryville, CA); Ashlee Nunes (Emeryville, CA)
Assignee: Amyris, Inc.
A61K8/347A61K8/31A61Q19/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,219,586
App. No.
17/375,512
Granted
Jan 11, 2022
Kind
B2
Abstract

Provided herein are compositions for delivering one or more cannabinoids to the skin of a subject and methods of using the compositions to deliver the one or more cannabinoids to the skin of a subject. The compositions contain a carrier that facilitates the delivery and permeation of cannabinoids to and through the skin. The carriers of the compositions contain squalane or mixtures of squalane and hemisqualane. The compositions described herein may serve as the base for the preparation of various cosmetics or various pharmaceuticals. The cosmetics or pharmaceuticals may be used to reduce inflammation, control pain, or prevent aging of the skin of a subject.

Claims (20)

1. A method of delivering a cannabinoid to a subject comprising applying a composition comprising a carrier and one or more cannabinoids to a skin area of the subject, wherein the carrier comprises squalane.

2. The method of claim 1 , wherein the composition is applied to the skin area in an amount of from about 0.1 mg/cm 2 to about 10 mg/cm 2 .

3. The method of claim 2 , wherein the composition is applied to the skin area in an amount of from about 1 mg/cm 2 to about 3 mg/cm 2 .

4. The method of claim 1 , wherein an effective amount of cannabinoid is delivered to the subject.

5. The method of claim 1 , wherein an effective amount of the composition is administered to the skin of the subject to reduce inflammation.

6. The method of claim 5 , wherein the composition is administered at least daily.

7. The method of claim 6 , wherein the composition is administered at least twice daily.

8. The method of claim 1 , an effective amount of the composition is administered the skin of the subject to reduce pain.

9. The method of claim 1 , wherein the one or more cannabinoids comprise cannabigerol (CBG) or cannabidiol (CBD).

10. A method of reducing inflammation in skin of a subject comprising applying an effective amount of a composition comprising a carrier and one or more cannabinoids to a skin area of the subject, thereby reducing inflammation, wherein the carrier comprises squalane.

11. The method of claim 10 , wherein the composition is administered to the skin area in an amount of from about 0.1 mg/cm 2 to about 10 mg/cm 2 .

12. The method of claim 11 , wherein the composition is administered to the skin area in an amount of from about 1 mg/cm 2 to about 3 mg/cm 2 .

13. The method of 10 , wherein the composition is administered at least daily.

14. The method of claim 13 , wherein the composition is administered at least twice daily.

15. The method of claim 10 , wherein the one or more cannabinoids comprise cannabigerol (CBG) or cannabidiol (CBD).

16. A method of reducing pain in a subject comprising applying an effective amount of a composition comprising a carrier and one or more cannabinoids to a skin area of the subject, thereby reducing pain, wherein the carrier comprises squalane.

17. The method of claim 16 , wherein the composition is administered to the skin area in an amount of from about 0.1 mg/cm 2 to about 10 mg/cm 2 .

18. The method of claim 17 , wherein the composition is administered to the skin area in an amount of from about 1 mg/cm 2 to about 3 mg/cm 2 .

19. The method of 16 , wherein the composition is administered at least daily.

20. The method of claim 16 , wherein the one or more cannabinoids comprise cannabigerol (CBG) or cannabidiol (CBD).

Assignments (6)
SECURITY INTEREST Recorded May 24, 2024
From: AMYRIS, INC.
To: EUAGORE, LLC
Reel/Frame 067528/0467 →
SECURITY INTEREST Recorded Aug 17, 2023
From: AMYRIS, INC.; AMYRIS CLEAN BEAUTY, INC.; AMYRIS FUELS, LLC; AB TECHNOLOGIES LLC; APRINNOVA, LLC; AMYRIS-OLINKA, LLC; ONDA BEAUTY INC.; UPLAND 1 LLC; AMYRIS ECO-FAB LLC; CLEAN BEAUTY 4U HOLDINGS, LLC; AMYRIS CLEAN BEAUTY LATAM LTDA; INTERFACES INDUSTRIA E COMERCIA DE COSMETICOS LTDA; AMYRIS BIOTECHNOLOGIA DO BRASIL LTDA; AMYRIS EUROPE TRADING B.V. (NETHERLANDS); AMYRIS BIO PRODCUTS PORTUGAL, UNIPESSOAL, LDA; BEAUTY LABS INTERNATIONAL LIMITED; AMYRIS UK TRADING LIMITED
To: EUAGORE, LLC
Reel/Frame 064619/0778 →
SECURITY INTEREST Recorded Aug 3, 2023
From: AMYRIS CLEAN BEAUTY, INC.; AMYRIS FUELS, LLC; AB TECHNOLOGIES LLC; AMYRIS, INC.
To: MUIRISC, LLC
Reel/Frame 064492/0518 →
CORRECTIVE ASSIGNMENT TO CORRECT THE LIST OF ASSIGNOR NAMES PREVIOUSLY RECORDED ON REEL 058204 FRAME 0494. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Nov 8, 2022
From: CHAN, DIVA; OTERI, RO; NUNES, ASHLEE
To: AMYRIS, INC.
Reel/Frame 061896/0945 →
SECURITY INTEREST Recorded Oct 18, 2022
From: AMYRIS, INC.
To: FORIS VENTURES, LLC
Reel/Frame 061703/0499 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 24, 2021
From: CHAN, DIVA; OTERI, RO
To: AMYRIS, INC.
Reel/Frame 058204/0494 →
Continuity (4)
Division 17206588 · Mar 19, 2021
Continuation PCTUS2020059357 · Nov 6, 2020
Provisional Application 62931978 · Nov 7, 2019
Related Publication 20210338549A1 · Nov 4, 2021